ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Crescent Biopharma Inc

Crescent Biopharma Inc (CBIO)

14,805
-0,285
( -1,89% )

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
14,805
( -1,89% )
Gebot
14,79
Fragen
14,85
Volumen
52.319
14,78 Tagesbereich 15,435
11,06 52-Wochen-Bereich 51,13
Marktkapitalisierung
Handelsende
15,09
Handelsbeginn
15,30
Letzte Trade
2
@
14.8
Letzter Handelszeitpunkt
20:27:55
Finanzvolumen
US$ 781.532
VWAP
14,9378
Durchschnittliches Volumen (3 Mio.)
19.338
Ausgegebene Aktien
14.800.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
9,80
Gewinn pro Aktie (EPS)
0,82
Erlöse
105,76M
Nettogewinn
12,09M

Über Crescent Biopharma Inc

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbo... GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Crescent Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CBIO. The last closing price for Crescent Biopharma was US$15,09. Over the last year, Crescent Biopharma shares have traded in a share price range of US$ 11,06 to US$ 51,13.

Crescent Biopharma currently has 14.800.000 shares in issue. The market capitalisation of Crescent Biopharma is US$223,33 million. Crescent Biopharma has a price to earnings ratio (PE ratio) of 9.80.

CBIO Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.445-8.8923076923116.2517.389914.7512388715.4989837CS
4-36.325-71.04439663651.1351.1311.066016415.91614079CS
12-36.325-71.04439663651.1351.1311.061933815.91614079CS
26-36.325-71.04439663651.1351.1311.06895015.91614079CS
52-36.325-71.04439663651.1351.1311.06434915.91614079CS
156-164.195-91.729050279317920911.0629654152.70691184CS
260-573.195-97.482142857158875511.06654238159.70955529CS

CBIO - Frequently Asked Questions (FAQ)

What is the current Crescent Biopharma share price?
The current share price of Crescent Biopharma is US$ 14,805
How many Crescent Biopharma shares are in issue?
Crescent Biopharma has 14.800.000 shares in issue
What is the market cap of Crescent Biopharma?
The market capitalisation of Crescent Biopharma is USD 223,33M
What is the 1 year trading range for Crescent Biopharma share price?
Crescent Biopharma has traded in the range of US$ 11,06 to US$ 51,13 during the past year
What is the PE ratio of Crescent Biopharma?
The price to earnings ratio of Crescent Biopharma is 9,8
What is the cash to sales ratio of Crescent Biopharma?
The cash to sales ratio of Crescent Biopharma is 1,12
What is the reporting currency for Crescent Biopharma?
Crescent Biopharma reports financial results in USD
What is the latest annual turnover for Crescent Biopharma?
The latest annual turnover of Crescent Biopharma is USD 105,76M
What is the latest annual profit for Crescent Biopharma?
The latest annual profit of Crescent Biopharma is USD 12,09M
What is the registered address of Crescent Biopharma?
The registered address for Crescent Biopharma is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Crescent Biopharma website address?
The website address for Crescent Biopharma is www.gyretx.com
Which industry sector does Crescent Biopharma operate in?
Crescent Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
WWWW International Inc
US$ 38,625
(15.374,76%)
178,68k
EVOKEvoke Pharma Inc
US$ 7,16
(169,17%)
127,96M
SUGPSU Group Holdings Ltd
US$ 1,08
(140,27%)
184,04M
BMGLBasel Medical Group Ltd
US$ 3,19
(75,27%)
76,75M
SCAGScage Future
US$ 6,16
(46,67%)
9,13M
PHHPark Ha Biological Technology Company Ltd
US$ 1,135
(-62,04%)
14,24M
RXSTRxSight Inc
US$ 7,94
(-37,92%)
14,67M
BGLBlue Gold Limited
US$ 38,08
(-30,00%)
455,27k
PETWag Group Company
US$ 0,1799
(-29,31%)
4,52M
SHOTWSafety Shot Inc
US$ 0,0317
(-26,96%)
1,33k
NCNANuCana PLC
US$ 0,0623
(12,05%)
1,63B
GIBOGIBO Holdings Ltd
US$ 0,03515
(-14,89%)
228,37M
PLUGPlug Power Inc
US$ 1,785
(25,70%)
200,73M
PROKProKidney Corporation
US$ 4,6912
(25,77%)
197,12M
SUGPSU Group Holdings Ltd
US$ 1,08
(140,27%)
184,04M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock